A novel catheter-based cardioneural ablation procedure reduced symptoms of vasovagal syncope, a condition that leads to fainting, by as much as 80% for patients with symptoms despite medical intervention and behavioral modification who did not desire permanent pacing.

With highly contagious new COVID-19 variants emerging and driving surges around the world at different times, will we reach a regular "COVID season" anytime soon?

The partnership will advance pain and addiction research and accelerate positive health outcomes in Arizona, Oklahoma and across the country.

The article discusses the importance of the recently announced Valley Fever Collaborative, a University of Arizona Health Sciences-led partnership with Arizona State University and Northern Arizona University.

Three new student programs aim to train the next generation of health care professionals and increase access to care across Arizona’s diverse communities.

Novel findings from the Center for Innovation in Brain Science indicate the APOEe4 genotype drives metabolic changes, regardless of patient sex.

The National Alliance on Mental Illness (USA) reports that one in five teens experiences a bout of depression and 8% have a major depressive disorder. Charles Raison, MD, a professor of psychiatry at the College of Medicine – Tucson, is quoted.

A University of Arizona Health Sciences study found that a specific genotype of the APOE gene is able to significantly influence metabolic changes and override sex-specific differences between men and women with Alzheimer’s disease.

Sairam Parthasarathy, MD, a critical care specialist and professor at the College of Medicine – Tucson, is leading the Community Engagement Alliance (CEAL) Against COVID-19 Disparities.